PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3281726-1	1988	Marrow cells from 5-fluorouracil (5-FU)-treated mice formed few or no mixed erythroid colonies when plated in semisolid medium with interleukin 3 (IL 3) and erythropoietin (Ep) alone.	Fluorouracil	18-32	erythropoietin	Mus musculus	157-171	
9253112-4	1997	A strong correlation between the number of CFU-Mk and HPP-CFC formation from 5-fluorouracil bone marrow cells was observed when these cells were stimulated with EPO in the presence of SCF and IL-3.	Fluorouracil	77-91	erythropoietin	Mus musculus	161-164	
8599970-5	1996	Furthermore, when lentinan administration was followed by administration of erythropoietin (Epo) in 5-FU-treated mice, increases in femoral marrow and splenic CFU-E formation and augmentation of reticulocyte counts were observed beyond the level observed in mice treated with Epo alone.	Fluorouracil	100-104	erythropoietin	Mus musculus	76-90	
8599970-5	1996	Furthermore, when lentinan administration was followed by administration of erythropoietin (Epo) in 5-FU-treated mice, increases in femoral marrow and splenic CFU-E formation and augmentation of reticulocyte counts were observed beyond the level observed in mice treated with Epo alone.	Fluorouracil	100-104	erythropoietin	Mus musculus	92-95	
8599970-5	1996	Furthermore, when lentinan administration was followed by administration of erythropoietin (Epo) in 5-FU-treated mice, increases in femoral marrow and splenic CFU-E formation and augmentation of reticulocyte counts were observed beyond the level observed in mice treated with Epo alone.	Fluorouracil	100-104	erythropoietin	Mus musculus	276-279	
18854306-8	2008	In short term transplant experiments, DYRK3-/- progenitors also supported enhanced erythroblast formation, and erythropoietic advantages due to DYRK3-deficiency also were observed in 5-fluorouracil-treated mice expressing a compromised erythropoietin receptor EPOR-HM allele.	Fluorouracil	183-197	erythropoietin	Mus musculus	236-250	
9741839-7	1998	EPO, pEPO, marrow responsiveness, or red cell volume were altered by either injections of rh-EPO, 5-fluorouracil, or phenylhydrazine, or by bleeding, or red cell transfusion.	Fluorouracil	98-112	erythropoietin	Mus musculus	0-3	
7601257-4	1995	Similarly, murine post-5 fluorouracil (5-FU) bone marrow cells or fetal liver cells, induced to express EpoR and stimulated by Epo, displayed a significant enhancement of megakaryocyte colony formation, particularly of the BFU-megakaryocyte (BFU-Mk) colony type.	Fluorouracil	25-37	erythropoietin	Mus musculus	104-107	
7601257-4	1995	Similarly, murine post-5 fluorouracil (5-FU) bone marrow cells or fetal liver cells, induced to express EpoR and stimulated by Epo, displayed a significant enhancement of megakaryocyte colony formation, particularly of the BFU-megakaryocyte (BFU-Mk) colony type.	Fluorouracil	39-43	erythropoietin	Mus musculus	104-107	
1564955-2	1992	Multilineage colony formation from mice that had been treated with 150 mg/kg 5-fluorouracil was assayed in cultures containing interleukin-3, interleukin-6, and erythropoietin.	Fluorouracil	77-91	erythropoietin	Mus musculus	161-175	
3281726-1	1988	Marrow cells from 5-fluorouracil (5-FU)-treated mice formed few or no mixed erythroid colonies when plated in semisolid medium with interleukin 3 (IL 3) and erythropoietin (Ep) alone.	Fluorouracil	34-38	erythropoietin	Mus musculus	157-171	
3958510-12	1986	These data suggest that multi-CSA and SA may be expressed by different factors and that 5-FU pre-treated marrow contains: a population of primitive multipotential progenitors which form large, mixed colonies in the presence of SCM + Epo, and a larger Epo-sensitive population which also requires HPCM + PMUE to form mixed colonies.	Fluorouracil	88-92	erythropoietin	Mus musculus	233-236	
3958510-12	1986	These data suggest that multi-CSA and SA may be expressed by different factors and that 5-FU pre-treated marrow contains: a population of primitive multipotential progenitors which form large, mixed colonies in the presence of SCM + Epo, and a larger Epo-sensitive population which also requires HPCM + PMUE to form mixed colonies.	Fluorouracil	88-92	erythropoietin	Mus musculus	251-254	
7084423-0	1982	Erythropoietin formation during hypoxia in mice with impaired responsiveness to erythropoietin induced by irradiation or 5-fluorouracil injection.	Fluorouracil	121-135	erythropoietin	Mus musculus	0-14	
7084423-0	1982	Erythropoietin formation during hypoxia in mice with impaired responsiveness to erythropoietin induced by irradiation or 5-fluorouracil injection.	Fluorouracil	121-135	erythropoietin	Mus musculus	80-94	
7084423-1	1982	Plasma erythropoietin levels during continuous exposure to hypobaric hypoxia in mice with marrow aplasia induced by whole body X-irradiation of 5-fluorouracil injection were higher than in control mice similarly exposed.	Fluorouracil	144-158	erythropoietin	Mus musculus	7-21	
5668151-0	1968	Effect of erythropoietin on early recovery of erythropoiesis in mice after sublethal dose of 5-fluorouracil.	Fluorouracil	93-107	erythropoietin	Mus musculus	10-24